Physician profile
Rohan Deo
NPI 1538906938
$782.27
in general payments reported to CMS, 2019-2025
14 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $326 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.70 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.86 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $61.63 | 2025 | Airsupra |
| Novo Nordisk INC | $57.62 | 2024-2025 | Ozempic, Rybelsus |
| Fresenius Kabi USA, LLC | $43.71 | 2024-2025 | Idacio |
| Janssen Biotech, INC. | $41.82 | 2025 | Rybrevant |
| Takeda Pharmaceuticals U.S.A., INC. | $33.49 | 2024 | Entyvio |
| Grifols USA, LLC | $32.37 | 2024 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $28.70 | 2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $28.35 | 2025 | |
| Alnylam Pharmaceuticals INC. | $25.83 | 2025 | Onpattro |
| Dexcom, INC. | $23.06 | 2025 | Dexcom G6 Transmitter |
| Actelion Pharmaceuticals US, INC. | $19.05 | 2025 | Opsumit |
| Glaxosmithkline, LLC. | $17.08 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohan Deo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.